Javascript must be enabled for this website to work.

#script { display:none; } #noScript{ width: 350px; height: 175px; text-align: center; background: white; padding: 35px; display: block; margin-top: -87px; top: 50%; position: absolute; border-bottom: 1px solid #c2c2c2; border-left: 1px solid #e6e6e6; border-right: 1px solid #e6e6e6; border-radius: 5px; -webkit-border-radius: 5px; -moz-border-radius: 5px; margin-left: 50%; left: -175px; } #noScript img{width:100%;} body{background:#f7f7f7;}

PBS broadens access to COPD triple therapy and lung cancer immunotherapy

FOT better than spirometry for identifying poor asthma control

Novel therapy success for ‘untreatable’ P. aeruginosa in CF lung transplant patient

RACP training program gets 79% approval rating from participants

Today’s disease names are less catchy, but also less likely to cause stigma

Cystic fibrosis

Kalydeco listed on PBS for children aged 12-24 months

22 Jul 2019

Respiratory medicine specialists have welcome the announcement that ivacaftor (Kalydeco) will be subsidised on the PBS for children aged 12-24 months with cystic fibrosis (CF) from 1 August. The drug is currently subsidised for about 280 patients over two years of age who have a G551D mutation or other class III gating mutations in the ...

Already a member?

Forgot my password

Not a member yet?

Join now for free, independent news relevant to your specialty. the limbic is intended for practicing health care professionals only.

Title: *

First name: *

Last name: *

Country: *

Email: *

Password: *

Password must contain at least 8 characters including 1 letter and 1 number.

AHPRA Number: * Find my AHPRA number

What's your primary area of interest? *

The limbic's weekly newsletter is a round up of key news highlights that's relevant to your specialty. The newsletter may contain advertising and educational or promotional material from carefully selected industry partners including pharmaceutical companies, government and not-for-profit organisations.

You will not receive advertisers only emails and your details will not be shared with any other party.

I would like to receive the limbic newsletter *

I have read and agree to the limbic Terms and Conditions & Privacy Policy *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cancel

Top Stories